News & numbers Pharmaceutical R&D investment Ranking 1 2 3 4 5 6 7 8 9 10 Company R&D expenditure $15.34bn $13.55bn $11.62bn $11.43bn $10bn $9.8bn $9.51bn $7.19bn $6.71bn $6.68bn Turnover $49.71bn $59.28bn $52.6bn $100.33bn $50.5bn $44.35bn $46.16bn $28.54bn $43bn $35.58bn


Percentage of total revenue spent on R&D


31% 23% 22% 11% 20% 22% 21% 25% 16% 19%


A note on fi nancial fi gures: Pharmaceutical sales account for varying degrees of total revenue for life science companies. In the case of some companies, the fi gures reported here apply only to the turnover amount and R&D expenses related to the segments of business that apply to pharmaceuticals. To compile this ranking, we used various public documents, meaning companies that haven’t disclosed their R&D spend for 2022 were not listed. To keep the currency consistent, we applied conversions based on the exchange rate at the time, meaning US dollar amounts may be subject to change with fl uctuations in currency values.


6 Clinical Trials Insight / www.worldpharmaceuticals.net


YummyBuum/www.shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41